AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PALISADE BIO, INC. Director's Dealing 2015

Jul 6, 2015

35274_dirs_2015-07-06_09a0d2c6-08d8-4eea-8565-b3dcd3462b63.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2015-07-01

Reporting Person: SMITH SANDFORD D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-01	Common Stock	A	106952	$0.00	Acquired	106952	Direct

Footnotes

F1: The shares represented are restricted stock grants pursuant to compensatory Annual Grant for director services. The shares vest quarterly on 9/30/15, 12/31/15, 3/31/15 and 6/30/15.